Table 3 The dynamics of changes in blood lipids observed during the course of treatment in patients with nonalcoholic steatohepatitis and concomitant obesity, mean ± SD

1

7.04 ± 0.28

5.96 ± 0.14

5.17 ± 0.11**

2

6.95 ± 0.24

5.50 ± 0.18**

4.51 ± 0.04**/***

1

3.25 ± 0.06

2.73 ± 0.09**

1.82 ± 0.05**

2

3.26 ± 0.05

2.21 ± 0.06 **/***

1.43 ± 0.03**/***

1

4.84 ± 0.03

3.75 ± 0.06**

2.94 ± 0.05*/**

2

4.81 ± 0.03

3.07 ± 0.04**/***

2.49 ± 0.03**/***

1

0.98 ± 0.03

(Men: 0.96 ± 0.04; Woman: 0.94 ± 0.03)

1.14 ± 0.02**

(Men: 1.16 ± 0.03; Woman: 1.12 ± 0.03)

1.31 ± 0.02*/**

(Men: 1.33 ± 0.03; Woman: 1.29 ± 0.03)

2

0.97 ± 0.02

(Men: 0.95 ± 0.03; Woman: 0.93 ± 0.04)

1.26 ± 0.01**/***

(Men: 0.97 ± 0.03; Woman: 0.93 ± 0.03)

1.42 ± 0.01**/***

(Men: 1.44 ± 0.04; Woman: 1.40 ± 0.03)

1

6.3 ± 0.06*

4.54 ± 0.04*/**

2.95 ± 0.04*/**

2

6.14 ± 0.08*

3.5 ± 0.05*/**/***

2.18 ± 0.03*/**/***